Russian recombinant human insulin — “Insuran R” and “Insuran NPH”

From 2003 on the base of the Institute’s Experimental biotechnology plant there is producing of the first Russian recombinant human insulin — “Insuran R” and “Insuran NPH”. For this development, scientists of the IBCh RAS with their leader academician Anatoly Miroshnikov received RF Government Prize in the field of science and technology in 2006.

News

  • Russian Academy of Sciences Elections – 2011 science news XII.28.11

    Eugene Grishin and Sergei Lukyanov have been elected full members of the Russian Academy of Sciences

  • Receptor with “non-traditional” orientation science news VI.10.11

    Receptor tyrosine kinases play a key role in regulation of cell proliferation and differentiation, as well as of cell migration and metabolism. Until now, it was thought that all ligands of these receptors are of protein or peptide nature. However, a recent study conducted by a group of IBCh RAS researchers led by Dr. Alexander Petrenko identified a receptor tyrosine kinase that works as a sensor of mildly alkaline media, i.e. it activates in response to increase in concentration of extracellular hydroxyl-anions. Notably, this receptor has previously been considered as orphan with its ligand not found.

  • The Future of Russian Science science news X.10.10

    Most of Russian scientists are concerned with the future of Russian Science. And there is no surprise: in 2011  the Goverment isn't planning to allocate additional funds to Science. So, Georgii Georgiev (a professor at the Institute of Gene Biology, RAS, and an adviser of the RAS) and Eugene Sverdlov (a professor at the Institute of Molecular Genetics, RAS, and an adviser of the RAS) wrote an article in "Science" (october, 2010) about their expectations.

Events